EPS Corporation
Mastering the Art of Global Business Expansion
Noriyuki Takai, Board Member, Executive Corporate Officer and Head of the Comprehensive Planning Office
Medical Affairs Services
Medical Affairs Services comprise specialized pharmaceutical and life sciences functions that bridge clinical research, regulatory compliance, and healthcare communication. They support evidence generation, scientific engagement with physicians, and post-market surveillance. These services ensure medical accuracy, ethical promotion, and strategic alignment between R&D, regulatory bodies, and commercial operations across global healthcare markets.
Solutions
Japan is home to the third-largest pharmaceutical market in the world. By 2029, the market value of new drugs and patented products in the country is projected to reach approximately 8.5 trillion yen, with a growth rate of 10.7 to 11.7 percent. Japan’s cancer therapeutic market alone is projected to nearly double and reach a value of USD 21.6 billion by 2032, with a compound annual growth rate (CAGR) of 8.7 percent during this period.
State of Industry
Medical Affairs Service Providers: Architecting the Future of Life Sciences
The life sciences sector is navigating an era of unprecedented scientific advancement, regulatory dynamism, and an intensified focus on delivering demonstrable value to patients and healthcare systems. Within this intricate ecosystem, Medical Affairs (MA) has decisively evolved from a traditionally supportive role to a central strategic pillar, guiding scientific exchange, evidence generation, and the articulation of product value. This strategic imperative has fueled the growth and sophistication of service providers and specialist organizations dedicated to delivering a comprehensive suite of MA capabilities to pharmaceutical, biotechnology, and medical device companies.
Leadership Perspective
Caidya
The Rub: Medical Affairs is Far More Than a Commodity in Rare and Genetic Disease
Henry David Cremisi, MD, FACP, Executive Medical Director, Medical Affairs
We are at the cusp of a new era in therapeutics. Rare and genetic diseases are providing targets for therapeutic intervention and increasingly yield life-changing results for patients and their families. Our tools of intervention are comprised of a spectrum of therapeutics, including oral small molecules, injectables, anti-sense oligonucleotides, gene therapies including CRISPR-Cas-9 and Prime Editing, enzyme replacement, and a host of novel delivery approaches to break barriers to delivery of the investigational product to the target site, including the eye, crossing the blood-brain barrier and beyond.
Medical Affairs Services Info
Q1
What Do Top Medical Affairs Services Providers Do?
Top Medical Affairs Services providers support pharmaceutical, biotechnology and medical device companies by managing scientific communication, clinical evidence support and healthcare stakeholder engagement throughout the product lifecycle. These services often include medical strategy development, scientific exchange, publication planning, field medical support and evidence generation activities. Many medical affairs service providers also assist organizations with regulatory communication, post-marketing medical support and key opinion leader engagement to help ensure accurate scientific information reaches healthcare professionals and regulatory stakeholders.
Q2
What Services Are Included in Medical Affairs Solutions?
Top Medical Affairs Services commonly include medical writing, medical information support, pharmacovigilance coordination, publication management and scientific advisory services. Medical affairs providers may also offer medical science liaison support, post-marketing surveillance assistance, healthcare professional education and real-world evidence programs. In many pharmaceutical and biotechnology organizations, medical affairs solutions are integrated with clinical development, regulatory affairs and commercialization strategies to support compliant scientific communication and product lifecycle management.
Q3
Why Is Demand for Medical Affairs Services Increasing?
Demand for Top Medical Affairs Services is increasing because pharmaceutical and biotechnology products are becoming more specialized and scientifically complex. Growth in biologics, personalized medicine, rare disease therapies and advanced medical devices has increased the need for expert scientific communication and evidence management. Companies expanding into international healthcare markets also require support navigating local regulations, medical education standards and stakeholder engagement requirements. The increasing importance of real-world evidence, post-market data and physician education is further driving demand for medical affairs expertise across the global life sciences sector.
Q4
How Are Top Medical Affairs Services Evaluated?
Pharmaceutical companies and healthcare organizations often evaluate Top Medical Affairs Services based on scientific expertise, therapeutic knowledge, regulatory understanding and global operational capability. Important considerations may include medical writing quality, healthcare professional engagement experience, compliance standards and the ability to manage cross-functional communication effectively. Medical affairs service providers are also assessed on their experience supporting clinical trials, post-marketing activities and evidence-based medical communication across different healthcare markets and therapeutic areas.
Q5
What Value Do Medical Affairs Services Deliver to Healthcare and Pharmaceutical Organizations?
Top Medical Affairs Services help pharmaceutical and biotechnology organizations improve scientific communication, support evidence-based decision-making and strengthen healthcare stakeholder relationships. Effective medical affairs programs can improve the accuracy of medical information shared with healthcare professionals while supporting regulatory compliance and patient safety. Medical affairs services may also help organizations manage product education, post-market surveillance and scientific publications more efficiently. For healthcare and life sciences companies, strong medical affairs support contributes to better clinical understanding and more informed treatment adoption.
Q6
How Are Innovation and Digital Technologies Transforming Medical Affairs Services?
Innovation is reshaping Top Medical Affairs Services through artificial intelligence, digital engagement platforms and advanced healthcare data analytics. Many medical affairs providers are adopting AI-assisted literature review systems, omnichannel scientific communication tools and real-world evidence analytics to improve medical insights and stakeholder engagement. Advances in decentralized clinical research, digital medical education and integrated healthcare data systems are also helping organizations manage scientific communication more effectively across global markets. These technologies are improving responsiveness, data interpretation and collaboration throughout the medical affairs ecosystem.
